The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells - Concepedia

Concepedia

Publication | Open Access

The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells

DOI Full Paper Access

21

Citations

27

References

2015

Year

Johannes Kraus, Marianne Kraus, Nora Liu, Lenka Bešše, Jürgen Bader, Paul P. Geurink, Gerjan de Bruin, Alexei F. Kisselev, Herman S. Overkleeft, Christoph Driessen

Cancer Chemotherapy and Pharmacology

References

	Year	Citations

Page 1